Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Difficulty coordinating movements and speech difficulties; Difficulty coordinating movements and speech difficulties; Difficulty coordinating movements and speech difficulties; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-711634. An 84-year-old male patient received second dose of BNT162B2 (COMIRNATY; Solution for injection; Lot number: unknown) via intramuscular route of administration on arm right on 26Feb2021 at 0.3 ug dose as SINGLE DOSE for COVID-19 immunization. The patient medical history included cardiac pacemaker insertion from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. On 18Mar2021, the patient had difficulty in coordinating movements and speech difficulties (aphasia, gait disturbance and motor dysfunction) (death). The patient died on an unknown date and the outcome of all events reported as fatal. It was not reported/unknown if an autopsy was performed or not. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Reporter''s Comments: My father wore a pacemaker in his heart.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166